The pharmacotherapy of low back pain
About 60–80% of patients visiting a physician have at some stage in their lives suffered from low back pain. The annual incidence in adults aged 35–55 years in developed countries is up to 45%.1 The differential diagnosis is broad and includes muscular strain, primary spine disease like disc herniat...
Main Author: | Oppel BW Greeff |
---|---|
Format: | Article |
Language: | English |
Published: |
AOSIS
2018-03-01
|
Series: | South African Family Practice |
Subjects: | |
Online Access: | https://safpj.co.za/index.php/safpj/article/view/4816 |
Similar Items
-
Pharmacotherapy for lumbago
by: A.E. Karateev
Published: (2014-05-01) -
Pharmacotherapy for lumbago
by: A.E. Karateev
Published: (2014-05-01) -
Therapy for acute nonspecific back pain: new additional opportunities
by: V. A. Golovacheva, et al.
Published: (2018-12-01) -
A Novel Algorithm to Identify Predictors of Treatment Response: Tapentadol Monotherapy or Tapentadol/Pregabalin Combination Therapy in Chronic Low Back Pain?
by: Jan C. Otto, et al.
Published: (2019-09-01) -
Pharmacotherapy of chronic back pain: Are there prospects?
by: G. I. Shvartsman, et al.
Published: (2017-09-01)